• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,180.72 -104.35
( -0.13%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
68,399.59 -1,338.10
(-1.92%)
Nikkei 225
10,685.41 33.64
(0.32%)
Forex
USD-INR
95.19 -0.09
(-0.09%)
EUR-INR
108.86 0.10
(0.10%)
GBP-INR
127.02 0.03
(0.03%)
JPY-INR
0.59 0.00
(-0.02%)

EQUITY - MARKET SCREENER

EPL Ltd
Industry :  Packaging
BSE Code
ISIN Demat
Book Value()
500135
INE255A01020
36.8613224
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPL
24.84
7861.71
EPS(TTM)
Face Value()
Div & Yield %
9.88
2
1.02
 

Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter
May 27,2026
Net profit of Medicamen Biotech rose 59.50% to Rs 3.86 crore in the quarter ended March 2026 as against Rs 2.42 crore during the previous quarter ended March 2025. Sales rose 104.83% to Rs 60.65 crore in the quarter ended March 2026 as against Rs 29.61 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.58% to Rs 9.64 crore in the year ended March 2026 as against Rs 7.11 crore during the previous year ended March 2025. Sales rose 21.67% to Rs 197.77 crore in the year ended March 2026 as against Rs 162.55 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales60.6529.61 105 197.77162.55 22
OPM %8.97-5.44 -9.918.53 -
PBDT6.792.97 129 19.2016.95 13
PBT5.062.49 103 11.989.88 21
NP3.862.42 60 9.647.11 36